| Retargeting of T lymphocytes to PSCA-or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR” A Feldmann, C Arndt, R Bergmann, S Loff, M Cartellieri, D Bachmann, ... Oncotarget 8 (19), 31368, 2017 | 111 | 2017 |
| A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform S Albert, C Arndt, A Feldmann, R Bergmann, D Bachmann, S Koristka, ... Oncoimmunology 6 (4), e1287246, 2017 | 99 | 2017 |
| Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology S Koristka, A Kegler, R Bergmann, C Arndt, A Feldmann, S Albert, ... Journal of autoimmunity 90, 116-131, 2018 | 69 | 2018 |
| Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy A Feldmann, A Hoffmann, R Bergmann, S Koristka, N Berndt, C Arndt, ... OncoImmunology 9 (1), 1785608, 2020 | 45 | 2020 |
| Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells N Mitwasi, A Feldmann, R Bergmann, N Berndt, C Arndt, S Koristka, ... Oncotarget 8 (65), 108584, 2017 | 45 | 2017 |
| Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells D Bachmann, R Aliperta, R Bergmann, A Feldmann, S Koristka, C Arndt, ... Oncotarget 9 (7), 7487, 2018 | 43 | 2018 |
| Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells S Koristka, P Ziller-Walter, R Bergmann, C Arndt, A Feldmann, A Kegler, ... Cancer Immunology, Immunotherapy 68 (9), 1401-1415, 2019 | 36 | 2019 |
| UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells C Arndt, LR Loureiro, A Feldmann, J Jureczek, R Bergmann, D Máthé, ... OncoImmunology 9 (1), 1743036, 2020 | 32 | 2020 |
| A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR C Arndt, A Feldmann, S Koristka, M Schäfer, R Bergmann, N Mitwasi, ... OncoImmunology 8 (11), 1659095, 2019 | 27 | 2019 |
| T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppression A Kegler, S Koristka, R Bergmann, N Berndt, C Arndt, A Feldmann, ... Oncoimmunology 8 (9), e1621676, 2019 | 19 | 2019 |
| Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab® J Jureczek, A Feldmann, R Bergmann, C Arndt, N Berndt, S Koristka, ... OncoTargets and therapy 13, 5515, 2020 | 18 | 2020 |
| An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells J Jureczek, R Bergmann, N Berndt, S Koristka, A Kegler, E Puentes-Cala, ... Scientific Reports 9 (1), 10547, 2019 | 18 | 2019 |
| Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy E Kittel-Boselli, KEG Soto, LR Loureiro, A Hoffmann, R Bergmann, ... Cancers 13 (19), 4785, 2021 | 17 | 2021 |
| Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management C Arndt, R Bergmann, F Striese, K Merkel, D Máthé, LR Loureiro, ... Cancers 14 (8), 1996, 2022 | 11 | 2022 |
| T Cell Mediated Conversion of a Non-Anti-La Reactive B Cell to an Autoreactive Anti-La B Cell by Somatic Hypermutation MP Bachmann, T Bartsch, CC Bippes, D Bachmann, E Puentes-Cala, ... International journal of molecular sciences 22 (3), 1198, 2021 | 9 | 2021 |
| And Yet It Moves: Oxidation of the Nuclear Autoantigen La/SS-B Is the Driving Force for Nucleo-Cytoplasmic Shuttling N Berndt, CC Bippes, I Michalk, T Bartsch, C Arndt, E Puentes-Cala, ... International Journal of Molecular Sciences 22 (18), 9699, 2021 | 9 | 2021 |
| Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies DI Sandoval Bojórquez, Z Janicijevic, B Palestina Romero, ... ACS sensors 8 (2), 576-586, 2023 | 8 | 2023 |
| Two Be or Not Two Be: The Nuclear Autoantigen La/SS-B Is Able to Form Dimers and Oligomers in a Redox Dependent Manner N Berndt, CC Bippes, I Michalk, D Bachmann, J Bachmann, ... International journal of molecular sciences 22 (7), 3377, 2021 | 7 | 2021 |
| Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells HA Saleh, N Mitwasi, M Ullrich, M Kubeil, M Toussaint, W Deuther-Conrad, ... Frontiers in Immunology 14, 1166169, 2023 | 4 | 2023 |
| Tunable Protein Stabilization In Vivo Mediated by Shield-1 in Transgenic Medaka A Froschauer, L Kube, A Kegler, C Rieger, HO Gutzeit PloS one 10 (7), e0131252, 2015 | 4 | 2015 |
